Calcitonin gene-related peptide (receptor) antibodies: an exciting avenue for migraine treatment

Por Antoinette MaassenVanDenBrink, Gisela M. Terwindt, Arn M. J. M. van den Maagdenberg
Publicado em 2018-02-01

European headache federation consensus on the definition of resistant and refractory migraine

Por Simona Sacco, Mark Braschinsky, Anne Ducros, Christian Lampl, Patrick Little, Antoinette Maassen van den Brink, Patricia Pozo-Rosich, Uwe Reuter, Elena Ruiz de la Torre, Margarita Sanchez Del Rio, Alexandra J. Sinclair, Zaza Katsarava, Paolo Martelletti
Publicado em 2020-06-01

Effects of two isometheptene enantiomers in isolated human blood vessels and rat middle meningeal artery – potential antimigraine efficacy

Por Alejandro Labastida-Ramírez, Eloísa Rubio-Beltrán, Kristian A. Haanes, René de Vries, Ruben Dammers, A. J. J. C. Bogers, Antoon van den Bogaerdt, Bruce L. Daugherty, Alexander H. J. Danser, Carlos M. Villalón, Antoinette MaassenVanDenBrink
Publicado em 2019-05-01

Correction to: Hormonal contraceptives and risk of ischemic stroke in women with migraine: a consensus statement from the European Headache Federation (EHF) and the European Societ...

Por Simona Sacco, Gabriele S. Merki-Feld, Karen Lehrmann Ægidius, Johannes Bitzer, Marianne Canonico, Tobias Kurth, Christian Lampl, Øjvind Lidegaard, E. Anne MacGregor, Antoinette MaassenVanDenBrink, Dimos-Dimitrios Mitsikostas, Rossella Elena Nappi, George Ntaios, Per Morten Sandset, Paolo Martelletti, on behalf of the European Headache Federation (EHF) and the European Society of Contraception and Reproductive Health (ESC)
Publicado em 2018-09-01